The NIH has awarded Miro Health a $2.5M grant to support the commercialization of their automated neurological and psychiatric diagnostic and treatment monitoring services for healthcare delivery. Miro Health’s unique, mobile technologies allow patients to remotely self-administer assessments of neurological, cognitive, and psychiatric conditions. The company’s patented technologies support unmatched, symptom-based differential diagnosis and monitoring and has previously been designated a Breakthrough Device by the FDA (Software as a Medical Device).
top of page
bottom of page